title: Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential.
authors.forename: Malini
authors.initials: M
authors.lastname: Guha
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; D053823:Hedgehog Proteins; C538724:HhAntag691; D011725:Pyridines